A role for COX-2 suppression of metastasis through nonsteroidal anti-inflammatory drugs (NSAID) has also been suggested in epidemiological studies (9), but it is unclear whether this reflects tumor cell–specific effects, anti-inflammatory activity, or alterations in platelet aggregation. This evidence concerns the gene PTGS2 and neoplasm.